CALO', LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 25.031
EU - Europa 3.393
AS - Asia 2.325
SA - Sud America 43
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
Totale 30.821
Nazione #
US - Stati Uniti d'America 24.980
CN - Cina 1.378
IT - Italia 861
FI - Finlandia 613
SG - Singapore 552
DE - Germania 490
SE - Svezia 483
UA - Ucraina 344
GB - Regno Unito 329
VN - Vietnam 257
IN - India 65
FR - Francia 58
NL - Olanda 56
IE - Irlanda 51
CA - Canada 46
BR - Brasile 36
JP - Giappone 22
SI - Slovenia 22
CH - Svizzera 17
PL - Polonia 17
RU - Federazione Russa 14
AU - Australia 9
ES - Italia 9
GE - Georgia 9
NZ - Nuova Zelanda 8
TR - Turchia 8
EU - Europa 7
ID - Indonesia 7
HK - Hong Kong 6
PH - Filippine 5
BE - Belgio 4
BG - Bulgaria 4
EC - Ecuador 4
MK - Macedonia 4
RS - Serbia 4
TW - Taiwan 4
MX - Messico 3
SA - Arabia Saudita 3
AL - Albania 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
IQ - Iraq 2
JO - Giordania 2
MY - Malesia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AT - Austria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
Totale 30.821
Città #
Fairfield 4.233
Woodbridge 2.360
Houston 2.172
Chandler 2.089
Ashburn 1.791
Wilmington 1.532
Seattle 1.492
Jacksonville 1.470
Cambridge 1.411
Ann Arbor 1.394
Princeton 738
Medford 444
San Diego 421
Beijing 333
Roxbury 331
Singapore 324
Des Moines 322
Nanjing 316
Helsinki 290
Dong Ket 257
Padova 257
Boardman 237
Shenyang 94
New York 88
Nanchang 86
Hebei 84
Guangzhou 82
London 57
Jiaxing 55
Ogden 54
Munich 53
Norwalk 53
Tianjin 53
Milan 44
Dublin 43
Redwood City 43
Changsha 40
Jinan 35
Mcallen 35
Kharkiv 31
Montréal 28
Falls Church 27
Kilburn 26
Washington 25
Vicenza 24
Amsterdam 23
Borås 23
Rome 22
Pune 20
Shanghai 20
Curitiba 18
Los Angeles 17
Zhengzhou 14
Nürnberg 12
Lausanne 11
Atlanta 10
Hefei 10
Kunming 10
Lappeenranta 10
Palermo 9
Prescot 9
Tbilisi 9
Acton 8
Bologna 8
Dronten 8
Hangzhou 8
Joetsu 8
Malo 8
Tappahannock 8
Chicago 7
Chiswick 7
Hounslow 7
Lanzhou 7
Ningbo 7
Silea 7
Simi Valley 7
Southwark 7
Venice 7
Detroit 6
Indiana 6
New Bedfont 6
Phoenix 6
Rockville 6
Turin 6
Como 5
Florence 5
Fuzhou 5
Haikou 5
Hong Kong 5
Hyderabad 5
Las Vegas 5
Mestre 5
Modena 5
Redmond 5
San Jose 5
Sava 5
Scorzè 5
Surabaya 5
Taizhou 5
Tokyo 5
Totale 25.856
Nome #
Potential role of phytochemicals in metabolic syndrome prevention and therapy 254
Ruolo dei fattori vasoattivi di origine endoteliale nella patogenesi dell'ipertensione arteriosa.Valutazione fisiopatologiche e terapeutiche 155
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 152
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 151
Endothelin-1 Drives Epithelial-Mesenchymal Transition In Hypertensive Nephroangiosclerosis 138
Searching for an additional treatment to slowing the progression of Fabry disease 136
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 130
THE MEDICAL AND ENDOVASCULAR TREATMENT OF ATHEROSCLEROTIC RENAL ARTERY STENOSIS (METRAS) STUDY: RATIONALE AND STUDY DESIGN 126
Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder 124
Cigarette smoking is associated with decreased Bone Gla-protein (BGP) levels in hemodialysis patients. 122
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 121
A UNIQUE CASE OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS FOLLOWING DEXAMETHASONE/BORTEZOMIB/THALIDOMIDE TREATMENT FOR MYELOMA 117
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 116
The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design. 115
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 114
Thymoma-associated renal pathology: Is renal biopsy always necessary? A clinical problem-solving exercise and teaching example for physicians. 114
Aldosterone, inflammation, and preeclampsia. 113
Oral burning with dysphagia and weight loss 113
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 112
A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis? 111
The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. 111
Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms 110
Salivary Phosphorus and Phosphate Content of Beverages: Implications for the Treatment of Uremic Hyperphosphatemia 109
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 108
Comment on: Hemodiafiltration in a critical dialysis patient with H1N1 influenza A 106
EPO induces rise in serum ADMA but does not prevent the increase in NO release: the likely involvement of HO-1 105
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro. 105
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients 105
Hypertension and Its Treatment in the Elderly 105
Salivary Phosphate-Binding Chewing Gum Reduces Hyperphosphatemia in Dialysis Patients 104
HO-1 Attenuates Hypertension-Induced Inflammation/Oxidative Stress: Support From Bartter's/Gitelman's Patients 104
Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways 103
IDIOPATHIC HYPERCALCIURIA: O2-NO RELATIONSHIP AND ALTERED BONE METABOLISM 103
Myocardial perfusion defects in Bartter and Gitelman syndromes 102
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. 102
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 102
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 102
Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients. 101
PHOS-FAKE or PHOS-FATAL - does intake of phosphate from foods lead to elevated plasma phosphate and its associated cardiovascular risks? 100
Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications. 100
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 100
Hemodiafiltration and oxidative stress in dialysis patients. 99
Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. 97
Identification of the mineralocorticoid receptor in human spermatozoa 97
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 96
Kidney Involvement in Asia Syndrome: Case Report of an Uncommon Nephrotic Syndrome 95
In vivo and in vitro neurotoxic action of plasma ultrafiltrate from uraemic patients 95
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 95
Bartter's and Gitelman's syndromes 95
Erythropoietin, heme oxygenase-1 and vascular tissue protective effects 95
Phosphate binders and management of hyperphosphataemia in end-stage renal disease 94
A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: The start of a good news/bad news story? 93
Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome) 93
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 92
Administering antihypertensive drugs after acute ischemic stroke: timing is everything 92
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis 92
Pseudohyperaldosteronism: pathogenetic mechanisms 92
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients. 92
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 92
[G-protein beta3-subunit gene 825T allele and cardiovascular risk] 92
Abnormalities of Gq-mediated cell signaling in Bartter's and Gitelman's syndome 91
Urinary NO2- and NO3- evaluation by an ion chromatography system 91
Ultrasound for the Clinical Management of Vascular Access Cannulation and Needle Position in Hemodialysis Patients 91
Carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1: studies in humans and in an animal model 90
Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients 90
High phosphate content beverages in dialysis patients: Relevance for hyperphosphatemia and cardiovascular risk. 89
Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke 89
Aldosterone and thrombosis formation: Implications for ischemic and atherosclerotic heart disease 89
Ultrafiltration in heart failure with cardiorenal syndrome. 89
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 89
Is the red cell morphology really useful to detect the source of hematuria? 89
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 88
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives 88
Obsessive-compulsive and post traumatic avoidance symptoms influence the response to antihypertensive therapy: Relevance in uncontrolled hypertension. 87
Pelvic-ureteric junction obstruction and hypertension with target organ damage: A case report and review of the literature. 87
Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus 86
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. 86
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 86
Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy 86
Licorice from antiquity to the end of the 19th century:applications in medical therapy 85
Oxidative stress and profibrotic action of aldosterone 85
ecNOS overexpression in CsA-treated renal transplant patients: Implications for CsA-induced hypertension 85
Aldosterone-mediated endothelial remodeling and oxidative stress 85
Apparent mineralcorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia and hypertension: Case report and appraisal of the pathophysiology. 85
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 85
SP021CARDIOVASCULAR-RENAL REMODELING IN FABRY DISEASE: POSSIBLE INVOLVEMENT OF OXIDATIVE STRESS. A MOLECULAR BIOLOGY APPROACH 85
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes 85
Mononuclear leukocyte mineralocorticoid receptors: a possible link between aldosterone and atherosclerosis 84
Aldosterone and refractory hypertension: A prospective cohort study 84
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes 84
Intracellular calcium signalling and vascular reactivity in Bartter's syndrome. 84
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension 83
Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies 83
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II 83
Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 83
Elderly patient: which vascular access? Choice and management of vascular access in the elderly patient. 83
Comment on: Acute kidney injury and rhabdomyolysis: a role for the regulator of G-protein signaling (RGS)-2 83
Psychological factors in resistant hypertension 82
Effect of dietary protein restriction on calcium metabolism in idiopathic hypercalciuria. 82
Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: effect of a new protocol adopted for a hemodialysis limited assistance center. 82
Totale 10.050
Categoria #
all - tutte 113.814
article - articoli 101.920
book - libri 353
conference - conferenze 0
curatela - curatele 0
other - altro 1.197
patent - brevetti 105
selected - selezionate 0
volume - volumi 1.623
Totale 219.012


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.346 1.079 209 105 547 675 507 580 723 661 584 373 303
2020/20214.665 200 376 218 316 190 406 217 412 648 389 472 821
2021/20226.045 105 848 529 541 266 319 233 658 285 131 551 1.579
2022/20234.614 1.136 395 118 486 818 515 13 301 540 39 187 66
2023/20242.524 116 269 247 178 179 280 202 177 141 83 277 375
2024/202540 40 0 0 0 0 0 0 0 0 0 0 0
Totale 31.265